369 related articles for article (PubMed ID: 29763806)
1. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M
Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806
[TBL] [Abstract][Full Text] [Related]
2. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
[TBL] [Abstract][Full Text] [Related]
3. New flavonoid -
Estrada-Valencia M; Herrera-Arozamena C; Pérez C; Viña D; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Laurini E; Pricl S; Rodríguez-Franco MI
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):712-727. PubMed ID: 31852270
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.
Knez D; Sova M; Košak U; Gobec S
Future Med Chem; 2017 May; 9(8):811-832. PubMed ID: 28504893
[TBL] [Abstract][Full Text] [Related]
5. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F
Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401
[TBL] [Abstract][Full Text] [Related]
6. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
[TBL] [Abstract][Full Text] [Related]
7. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of BACE1, MAO-B, cholinesterase enzymes, and anti-amyloidogenic potential of selected natural phytoconstituents: Multi-target-directed ligand approach.
Chowdhury S; Kumar S
J Food Biochem; 2021 Jan; 45(1):e13571. PubMed ID: 33249607
[TBL] [Abstract][Full Text] [Related]
9. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
Li Q; He S; Chen Y; Feng F; Qu W; Sun H
Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
Gabr MT; Abdel-Raziq MS
Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
[TBL] [Abstract][Full Text] [Related]
11. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
[TBL] [Abstract][Full Text] [Related]
12. Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives.
Wang Y; Sun Y; Guo Y; Wang Z; Huang L; Li X
J Enzyme Inhib Med Chem; 2016; 31(3):389-97. PubMed ID: 25798687
[TBL] [Abstract][Full Text] [Related]
13. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
[TBL] [Abstract][Full Text] [Related]
14. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
Khalid S; Zahid MA; Ali H; Kim YS; Khan S
BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
Weinreb O; Amit T; Bar-Am O; Youdim MB
Br J Pharmacol; 2016 Jul; 173(13):2080-94. PubMed ID: 26332830
[TBL] [Abstract][Full Text] [Related]
17. Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease.
Hafez DE; Dubiel M; La Spada G; Catto M; Reiner-Link D; Syu YT; Abdel-Halim M; Hwang TL; Stark H; Abadi AH
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2175821. PubMed ID: 36789662
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.
Sun Y; Chen J; Chen X; Huang L; Li X
Bioorg Med Chem; 2013 Dec; 21(23):7406-17. PubMed ID: 24128814
[TBL] [Abstract][Full Text] [Related]
19. Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy.
Zagórska A; Jaromin A
Molecules; 2020 Jul; 25(15):. PubMed ID: 32717806
[TBL] [Abstract][Full Text] [Related]
20. Multi-target-directed ligands in Alzheimer's disease treatment.
Bajda M; Guzior N; Ignasik M; Malawska B
Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
